Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study-Reference-Cited by-同舟云学术

Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study

Published:2024-03 Issue:3 Volume:9 Page:218-228
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Israelsen Mads,Torp Nikolaj,Johansen Stine,Hansen Camilla Dalby,Hansen Emil Deleuran,Thorhauge Katrine,Hansen Johanne Kragh,Villesen Ida,Bech Katrine,Wernberg Charlotte,Andersen Peter,Lindvig Katrine Prier,Tsochatzis Emmanuel A,Thiele Maja,Rinella Mary E,Krag Aleksander

Funder

Horizon 2020

Publisher

Elsevier BV

Reference28 articles.

1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature;Rinella;J Hepatol,2023

2. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies;Hart;BMJ,2010

3. Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus;Mallet;J Hepatol,2022

4. Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis;Israelsen;Clin Gastroenterol Hepatol,2022

5. Development and validation of a model to predict incident chronic liver disease in the general population: the CLivD score;Åberg;J Hepatol,2022

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

2. Plasma cathepsin D as an early indicator of alcohol-related liver disease;JHEP Reports;2024-09

3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

4. From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction;Metabolism and Target Organ Damage;2024-08-28

5. Changes in the epidemiological trends of primary liver cancer in the Asia–Pacific region;Scientific Reports;2024-08-22